Clinical trial
Safety Study of ME-609 for Treatment of Herpes Simplex Labialis in Adolescents
NCT00375570 · Medivir, Industry · Completed
Key facts
| NCT number | NCT00375570 |
|---|---|
| Title | Safety Study of ME-609 for Treatment of Herpes Simplex Labialis in Adolescents |
| Official title | An Open Label, Multi-Centre, Phase III, Subject Initiated Safety Study of ME-609 in Treatment of Recurrent Herpes Simplex Labialis in Adolescents |
| Lead sponsor | Medivir, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Herpes Labialis |
| Intervention type | Drug |
| Interventions | ME-609 |
| Enrollment | 254 |
| Start date | Oct 1, 2006 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Sep 13, 2006 |
| Last update posted | Aug 18, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: